Day: January 20, 2025

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, Norway, 20 January 2025 – Ensurge Micropower ASA (“Ensurge” or the “Company”) (OSE: ENSU, and OTCQB: ENMPY) has made significant advancements in developing and producing the solid-state microbatteries.  Key Progress and AchievementsEncapsulation: Ensurge has resolved the encapsulation issues of the battery stack through process optimization and material selection. Battery performance: Ensurge is validating improvements to address leakage-related yield loss that will ensure high performance...

Helsinki, January 20th, 2025 – Virtune, the Swedish regulated crypto asset manager, today announced the listing of Finland’s first crypto exchange-traded products (ETP) on Nasdaq Helsinki. This makes it easy and secure for Finnish investors to invest in crypto assets through proven and well-established financial instruments in the local currency. Virtune has made history as the first company to list crypto Exchange Traded Products (ETPs) on Nasdaq Helsinki. This groundbreaking launch introduces multiple crypto ETPs to the Finnish market, marking a significant first for the country’s financial sector. The ETPs are now trading in euro and are accessible to investors through major Nordic financial institutions, including Nordnet and other established brokers. This launch represents several key firsts for Finland’s financial...

On 2 January 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 70 of 23 December 2024. Under the programme, Schouw & Co. will acquire shares for up to DKK 50 million during the period 2 January to 31 March 2025. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount    Accumulated until 10  January 2025 11,700 549.74 6,431,987    Monday, 13 January 2025 1,900 539.53 1,025,107    Tuesday, 14 January 2025 1,900 539.48 1,025,012    Wednesday, 15 January 2025 1,900 542.49 1,030,731    Thursday, 16 January 2025 1,900 544.69 1,034,911    Friday,...

TORONTO, Jan. 20, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it has executed an agreement with Merhavim Mental Health Centre of Beer Yaakov, Israel (“Merhavim”). All data generated in the clinical trial, entitled “MDMA Assisted Psychotherapy for PTSD of Early Sexual Trauma Compared to All Trauma in Adulthood”, will be licensed to PharmAla for regulatory and commercial purposes in exchange for the clinical trial material, which will be provided by PharmAla on a zero-cost basis. MAPS Israel, an Israeli non-profit organization whose mission is to develop psychedelic research and educational...

PRESS RELEASE Paris, 20 January 2025 Ramsay Santé launches the repricing of its €1,025m TLB4 due 2031On 13 August 2024, Ramsay Santé closed an Amend & Extend of its €1,650m Senior Debt facilities, including a €1,025m 7-year TLB4 priced at E+400bps. On the back of currently favorable market conditions, Ramsay Santé is now looking to reprice its €1,025m TLB4. This transaction is arranged by BNP Paribas and Crédit Agricole CIB as Physical Bookrunners. The completion of the transaction is subject to market conditions.About Ramsay Santé Ramsay Santé is the leader in private hospitalisation and primary care in Europe. The Group has 38,000 employees and works with nearly 9,300 practitioners to treat more than 12 million patients per year in its 465 facilities and 5 countries: France, Sweden, Norway, Denmark and Italy. Ramsay Santé offers...

Oslo, 20 January 2025: Scatec ASA, a leading renewable energy solutions provider, has signed a 15-year Contract-for-Difference (CfD) with Opcom, the Romanian electricity market operator. The CfD will cover approximately 70% of the estimated production from a 190 MW solar portfolio, with the remaining production being sold in the Romanian wholesale electricity market. The contracts were awarded in the first CfD auction in Romania funded by the EU Modernisation Fund. The Modernisation Fund is an EU programme established to support selected member states to meet their energy targets. Approximately 1.5 GW of solar PV and onshore wind was awarded in this first round in Romania, while the remainder of a total auction plan of 5 GW is expected to be awarded in 2025. With this award, Scatec will advance its first project portfolio in the country...